CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-02 | 5AM Ventures V, L.P. 10% owner | Conversion · Series A Preferred Stock | −17,161,644 | 0 | ||
| 2021-11-02 | 5AM Ventures V, L.P. 10% owner | Conversion · Series A Preferred Stock | −4,082,613 | 0 | ||
| 2021-11-02 | 5AM Ventures V, L.P. 10% owner | Conversion · Series B Preferred Stock | −1,841,620 | 0 | ||
| 2021-11-02 | 5AM Ventures V, L.P. 10% owner | Conversion · Series B Preferred Stock | −2,302,026 | 0 | ||
| 2021-11-02 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion | +3,816,760 | 3,816,760 | ||
| 2021-11-02 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion | +509,024 | 4,325,784 | ||
| 2021-11-02 | MPM BIOVENTURES 2018, L.P. 10% owner | Purchase | +100,000 | $20.00 | $2.0M | 4,425,784 |
| 2021-11-02 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion · Series A Preferred Stock | −27,617,675 | 0 | ||
| 2021-11-02 | MPM BIOVENTURES 2018, L.P. 10% owner | Conversion · Series B Preferred Stock | −3,683,241 | 0 | ||
| 2021-11-02 | MPM BioVentures 2014, L.P. 10% owner | Conversion | +3,816,760 | 3,816,760 | ||
| 2021-11-02 | MPM BioVentures 2014, L.P. 10% owner | Conversion | +509,024 | 4,325,784 | ||
| 2021-11-02 | MPM BioVentures 2014, L.P. 10% owner | Purchase | +100,000 | $20.00 | $2.0M | 4,425,784 |
| 2021-11-02 | MPM BioVentures 2014, L.P. 10% owner | Conversion · Series A Preferred Stock | −27,617,675 | 0 | ||
| 2021-11-02 | MPM BioVentures 2014, L.P. 10% owner | Conversion · Series B Preferred Stock | −3,683,241 | 0 | ||
| 2021-11-02 | Foley Todd Director | Conversion | +3,816,760 | 3,816,760 | ||
| 2021-11-02 | Foley Todd Director | Conversion | +509,024 | 4,325,784 | ||
| 2021-11-02 | Foley Todd Director | Purchase | +100,000 | $20.00 | $2.0M | 4,425,784 |
| 2021-11-02 | Foley Todd Director | Conversion · Series A Preferred Stock | −27,617,675 | 0 | ||
| 2021-11-02 | Foley Todd Director | Conversion · Series B Preferred Stock | −3,683,241 | 0 | ||
| 2021-11-02 | ROCHE HOLDING LTD 10% owner | Conversion | +2,495,385 | 2,495,385 |
Page 28 of 29 · 577 trades